All lobbying filings

VENABLE LLP

Lobbying for DRUGS FOR NEGLECTED DISEASES INITIATIVE NORTH AMERICA · Non-profit product development partnership

Filing 3rd Quarter - Report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 14, 2025

Income

$10,000.00

What the client paid this registrant for the period.

Client based in

New York

Official filing document

Lobbying activity 1

Budget/Appropriations

FY 2026 Labor, Health and Human Services, Education and State and Foreign Operations funding for global health research and development and neglected tropical diseases FY 2026 global health research and development funding Issues related to global health

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.